MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Accounting Policy > Pharmaceuticals > Accounting Policy followed by Everest Organics - BSE: 524790, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > ACCOUNTING POLICY - Everest Organics
Everest Organics
BSE: 524790|ISIN: INE334C01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Everest Organics is not traded in the last 30 days
Everest Organics is not listed on NSE
« Mar 10
Accounting Policy Year : Mar '11
a) Accounting Assumptions
 
 These Financial Statements have been prepared under the historical cost
 convention in accordance with the generally accepted accounting
 principles and the provisions of the Companies Act, 1956 as adopted
 consistently by the company and the accounting standards prescribed by
 the Institute of Chartered Accountants of India with revenues
 recognized and expenses accounted for on their accrual including
 provisions/ adjustments for committed obligation and amount determined
 as payable or receivable during the year.
 
 b) Fixed Assets
 
 Fixed Assets are stated at historical cost of acquisition net of
 CENVAT, net of APVAT, which is inclusive of freight, installation
 charges, duties and incidental expenses and the proportionate
 expenditure and interest incurred during the installation period
 capitalized.
 
 c) Depreciation
 
 Depreciation on fixed assets is provided on the basis of straight line
 method at the rates provided for in the Schedule - XIV of the Companies
 Act, 1956 for the actual period of the usage of the assets, with Plant
 & Machinery being treated as continuous processing machinery.
 
 d) Inventories
 
 Raw materials are valued at the lower of the cost or market value.
 Work-in-process is valued at cost of raw materials and proportionate
 overheads. Finished goods are valued at lower of the cost or market
 value/net realizable value. Cost includes all charges incurred in
 relation to the goods.
 
 e) Research & Development Expenditure
 
 It is the policy of the company to transfer the Research & Development
 Expenditure on capital items to assets and depreciation is charged
 thereon accordingly at the applicable rates and Revenue expenditure on
 Research and development is charged off to Profit & Loss in the year in
 which it is incurred. During the year the Company has not incurred
 expenditure of capital nature on R&D.
 
 f) Employee Benefits :
 
 Contributions to defined contribution retirement benefit schemes are
 generally recognized as an expense when employees have rendered
 services entitling them to contributions.  Accordingly company provided
 for payment of Gratuity. However, the company has not provided for
 leave encashment. The company has not made any contribution to these
 employee benefits.
 
 g) Impairment of Assets
 
 The Company assesses, from time to time, as to whether there is any
 indication that an asset is impaired. However the management states
 that there has been no impairment loss during the year.
Source : Dion Global Solutions Limited
Quick Links for everestorganics
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.